Gastrointestinal Bleeding Treatment Market to Grow with a CAGR of 5.81% through 2029

Increasing research funding and collaboration and supportive stringent regulatory standard are the drivers for the Global Gastrointestinal Bleeding Treatment Market.

According to TechSci Research report, “Gastrointestinal Bleeding Treatment Market– Global Industry Size, Share, Trends, Competition Forecast & Opportunities, 2019-2029F”, Global Gastrointestinal Bleeding Treatment Market was valued at USD 557.67 million in 2023 and will see an steady growth in the forecast period at a CAGR of 5.81% through 2029. Minimally invasive techniques for treating gastrointestinal bleeding typically involve smaller incisions or endoscopic methods, contrasting with traditional open surgery. This approach results in decreased postoperative discomfort, less scarring, and quicker recovery periods, ultimately enhancing patient satisfaction and adherence to treatment. Compared to open surgery, minimally invasive procedures often lead to shorter hospital stays, enabling patients to return home sooner and resume normal activities promptly. This not only improves patient comfort and convenience but also reduces healthcare expenses linked with extended hospitalization and postoperative care.

The use of minimally invasive procedures for gastrointestinal bleeding treatment is associated with a reduced risk of complications, such as wound infections, bleeding, and organ damage, in comparison to conventional surgical methods. These procedures minimize trauma to surrounding tissues and organs, thereby enhancing safety profiles and overall patient outcomes. Endoscopic and minimally invasive techniques allow targeted intervention for gastrointestinal bleeding by enabling healthcare providers to visualize and precisely address bleeding lesions and vascular abnormalities within the gastrointestinal tract. Approaches like endoscopic hemostasis, angiographic embolization, and endoscopic mucosal resection (EMR) aid in identifying and controlling bleeding sources while preserving healthy tissue.

Treatment for gastrointestinal bleeding often entails intricate regimens involving medications, dietary adjustments, lifestyle modifications, and follow-up visits. Patients may encounter challenges in adhering to these multifaceted plans, particularly if they find them overwhelming or incompatible with their daily routines. Gastrointestinal bleeding symptoms such as abdominal pain, nausea, vomiting, and fatigue can impact patients' overall well-being and quality of life, potentially reducing their motivation and ability to comply with treatment recommendations, especially if they experience discomfort or adverse effects from medications or procedures. Patients with gastrointestinal bleeding may also experience psychological distress, anxiety, depression, and fear concerning their condition, treatment, and prognosis. These emotional factors can influence patients' readiness and capability to adhere to treatment plans, leading to noncompliance, treatment avoidance, and disengagement from healthcare services.

                                                                                             

Browse over XX market data Figures spread through XX Pages and an in-depth TOC on "Global Gastrointestinal Bleeding Treatment Market”

  

The Global Gastrointestinal Bleeding Treatment Market is segmented into Product, GI Tract Division, End Users, regional distribution, and company.

Based on its Product, the Endoscopic Hemostatic Devices segment experienced rapid growth in the Global Gastrointestinal Bleeding Treatment Market in 2023. Endoscopic hemostatic devices are specialized instruments utilized in endoscopic procedures to achieve hemostasis, which involves controlling and stopping bleeding within the gastrointestinal tract. These devices are designed to be inserted through an endoscope, enabling clinicians to directly visualize and treat bleeding lesions. The growth of this sector is primarily propelled by the increasing utilization of endoscopic procedures for managing gastrointestinal bleeding. Endoscopic hemostatic devices offer a less invasive option compared to traditional surgical methods, delivering precise and targeted treatment while minimizing patient discomfort and recovery duration. As both healthcare providers and patients acknowledge the advantages of minimally invasive approaches, there has been a notable rise in demand for endoscopic hemostatic devices.

The burgeoning popularity of endoscopic hemostatic devices is further fueled by technological advancements. Manufacturers continually innovate to enhance the efficacy, safety, and user-friendliness of these devices. Incorporating advanced features like hemostatic clips, band ligation systems, thermal coagulation probes, and injection needles enables clinicians to effectively address various bleeding lesions, including ulcers, varices, and vascular malformations. The adaptability of endoscopic hemostatic devices facilitates customized treatment strategies tailored to the specific characteristics of the bleeding lesion and the patient's clinical status. For instance, hemostatic clips can mechanically seal bleeding vessels, while thermal coagulation probes apply controlled heat energy to cauterize bleeding tissue. This versatility broadens the applicability of endoscopic hemostatic devices across diverse clinical scenarios, contributing to their widespread adoption.

Major companies operating in Global Gastrointestinal Bleeding Treatment Market are:

• Boston Scientific Corporation
• Olympus Corporation
• CONMED Corporation
• Ovesco Endoscopy AG
• Erbe Elektromedizin GmbH
• Steris Plc
• US Medical Innovations, LLC.
• Pfizer Inc.

 

Download Free Sample Report

Customers can also request for 10% free customization on this report

 

“The Global Market for Gastrointestinal Bleeding Treatment is experiencing notable expansion, driven by several factors including the growing acceptance of minimally invasive treatment methods, advancements in endoscopic technology, and the increasing prevalence of gastrointestinal bleeding disorders worldwide. Supportive reimbursement policies and improvements in healthcare infrastructure contribute to market growth. Asia Pacific region is witnessing rapid growth spurred by escalating disease rates, rising healthcare expenditure, and heightened awareness regarding the importance of early detection and treatment of gastrointestinal bleeding. The market is poised for sustained expansion as the demand for efficient and minimally invasive treatment options for gastrointestinal bleeding continues to rise on a global scale”, said Mr. Karan Chechi, Research Director of TechSci Research, a research-based Global management consulting firm.

“Gastrointestinal Bleeding Treatment Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Product (Endoscopic Hemostatic Devices (Thermal Devices, Mechanical Devices), Closure Devices, Others), By GI Tract Division (Upper GI Tract, Lower GI Tract), By End Users (Hospital/Clinics, Ambulatory Surgical Centres, Others), By Region, and By Competition, 2019-2029F”, has evaluated the future growth potential of Global Gastrointestinal Bleeding Treatment Market and provides statistics & information on market size, structure and future market growth. The report intends to provide cutting-edge market intelligence and help decision makers take sound investment decisions. Besides, the report also identifies and analyzes the emerging trends along with essential drivers, challenges, and opportunities in Global Gastrointestinal Bleeding Treatment Market.

 

Contact

TechSci Research LLC

420 Lexington Avenue, Suite 300,

New York, United States- 10170

Tel: +1-332-258-6602

Email: [email protected]

Website: www.techsciresearch.com